Conversations
Reindustrialization and Deep Tech Investing with 8090 Industries’ Grant Brown
Grant Brown is a principal at 8090 Industries, an early-stage industrial deep tech venture firm backing the next generation of industrialists.
Conversations
Grant Brown is a principal at 8090 Industries, an early-stage industrial deep tech venture firm backing the next generation of industrialists.
Newsletters
Plus: Google measures quantum echoes, money pours into dual use startups, AI-designed compounds kill drug resistant bacteria, solution to the CIA's Kryptos sculpture, using jet engines for data centers, and more.
Conversations
Alexander Regnat is co-founder and managing director of kiutra, a Munich-based company developing magnetic refrigeration systems for quantum computing and research applications.
Conversations
Will Purvis is the co-founder and CEO of Kaio Labs, a company using automation and machine learning to develop modular reactors that convert waste emissions into chemicals.
Newsletters
Plus: Acoustic wildfire defense, Starship's successful flight, self-driving drone-launching cop cars, ChatGPT erotica, advanced materials for fusion energy, artificial neurons interface with living cells, and more.
Conversations
Leo Banchik is a director at Voyager Ventures, a VC focused on early stage climate technology companies creating the foundation of a decarbonized global economy.
Newsletters
Plus: Nobel Prize winners, Starlink satellites burning, SpaceX dominates Space Force contracts, billionaires shape biotech, cyberspace battlegrounds, Firefly's big acquisition, North Korean hackers steal billions in BTC, and more.
The most widely read newsletter in deep tech. Get exclusive interviews, deals, and news from the frontier in your inbox. Every Friday.
Plus: Avalanche's desktop fusion reactor, NASA's X-59 goes supersonic, NY lawmakers pass first in US data center moratorium, China's big bet on big nuclear reactors, and more.
Viktor Shpakovsky is an investment partner at Beyond Earth Ventures, a $30 million venture capital fund investing in transformative deep tech across space tech, robotics, energy, and compute.
Plus: Agtech investment is booming, SpaceX outlines plans for Starfall re-entry vehicles, AI executives call for stricter regulations on synthetic biology, the people who want AI to replace humanity, and more.
Brian Wilcove is the managing director of America's Frontier Fund (AFF), a sovereign-aligned venture capital firm investing in frontier technologies to strengthen U.S. innovation and economic competitiveness.
Plus: Blue Origin's mega-rocket explodes, race to mine the deep sea, IBM's first pure-play quantum chip foundry, NASA selects companies for moon base awards, and more.
Plus: Biomanufacturing to reshape organ transplants, grid batteries are booming, quantum's make-or-break moment, growing chickens in 3D printed eggs, Japan sells out of robot wolves, in-space refueling demo, and more.
Plus: Helium-3 lunar gold rush, Virgin Galactic to begin commercial service, Cowboy files for 20k orbital data centers, non-viral gene therapy, real life gundams, and more.
Plus: China opens rocket launches to international satellites, the future of IVF, a geothermal IPO, big tech targets drug discovery, DARPA eyes commercial space boom, and more.
Plus: Pentagon's drone spending spree, air taxis come to NYC, Zuck's virtual biology initiative, DeepSeek's new model, FDA wants to accelerate clinical trails with AI, and more.
Plus: New Glenn suffers upper stage malfunction, China ramps up satellite capacity, cracks in fusion's funding boom, robot marathon, slime-like artificial muscles, cocaine-fueled salmon, and more.
Paul Veugen is co-founder and partner at NP-Hard Ventures, an Amsterdam-based early-stage venture capital firm investing in pre-seed and seed companies solving the hardest problems across robotics, defense tech, and foundational infrastructure.
Plus: nuclear reactors on the moon, implantable pharmacies, 3D printing batteries, first complete human genome loaded onto quantum computer, Science Corp gets ready for brain implant, ARPA-E doubles down on fusion, and more.